Luis Muniz-Feliciano

The University of Texas MD Anderson Cancer Center — United States

Immunology and Microbiology · Life Sciences

19h-index1.6kcitations70works7.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(57), CAR-T cell therapy research(45), Cancer Immunotherapy and Biomarkers(17), T-cell and B-cell Immunology(13), Cytomegalovirus and herpesvirus research(7)

Publications70 total

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models
Blood Cancer Discovery·2025· 1 citedOpen Access
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Cancer Cell·2025· 12 citedOpen Access
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells
Nature·2025· 24 citedOpen Access
Abstract 3763: Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency
Cancer Research·2025
Abstract 6396: CREM is a regulatory checkpoint of CAR and IL-15 signaling in NK cells
Cancer Research·2025
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells
Cell Reports·2025· 6 citedOpen Access
343 Oncolytic viruses induce sustained anti-tumor cytotoxicity in NK cells
Regular and Young Investigator Award Abstracts·2024Open Access
Data from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Video 2 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Figure S4 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024· 1 citedOpen Access
Supplementary Table S2 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Figure S5 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Figure S6 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Table S1 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Figure S2 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Video 1 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Figure S3 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
Supplementary Figure S1 from CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024Open Access
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
Science Translational Medicine·2024· 22 citedOpen Access
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Cancer Cell·2024· 63 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

May Daher(44), Rafet Başar(44), Pinaki P. Banerjee(43), Elizabeth J. Shpall(43), Nadima Uprety(42), Katayoun Rezvani(42), Ken Chen(40), Mayra Shanley(38), Ana Karen Nunez Cortes(37), Enli Liu(35), Emily L. Ensley(34), Mecit Kaplan(32), Vakul Mohanty(31), Sunil Acharya(31), Natalie W. Fowlkes(31), Ye Li(30), David Marín(26), Richard E. Champlin(25), Paul Lin(25), Mayela Carolina Mendt(24)